IC
GILD icon

IEQ Capital’s Gilead Sciences GILD Stock Holding History

IEQ Capital’s Portfolio GILD Stock Details GILD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$4.26M Buy
33,739
+15,992
+90% +$2.11M 0.02% 550
2026
Q1 		$2.47M Sell
17,747
-104,200
-85% -$14.6M 0.01% 694
2025
Q4 		$15M Buy
121,947
+11,133
+10% +$1.35M 0.04% 254
2025
Q3 		$12.3M Sell
110,814
-7,881
-7% -$896K 0.04% 276
2025
Q2 		$13.2M Buy
118,695
+12,705
+12% +$1.35M 0.08% 193
2025
Q1 		$11.9M Buy
105,990
+39,330
+59% +$4.06M 0.09% 169
2024
Q4 		$6.16M Sell
66,660
-15,591
-19% -$1.4M 0.06% 231
2024
Q3 		$6.9M Buy
82,251
+13,036
+19% +$995K 0.08% 159
2024
Q2 		$4.75M Buy
69,215
+2,453
+4% +$164K 0.06% 195
2024
Q1 		$4.89M Sell
66,762
-2,153
-3% -$166K 0.07% 183
2023
Q4 		$5.58M Buy
68,915
+8,220
+14% +$640K 0.09% 144
2023
Q3 		$4.55M Buy
60,695
+933
+2% +$71.8K 0.09% 144
2023
Q2 		$4.61M Buy
59,762
+1,788
+3% +$143K 0.09% 150
2023
Q1 		$4.81M Sell
57,974
-3,875
-6% -$321K 0.11% 132
2022
Q4 		$5.31M Buy
61,849
+4,954
+9% +$392K 0.15% 118
2022
Q3 		$3.51M Buy
56,895
+11,118
+24% +$701K 0.1% 152
2022
Q2 		$2.83M Sell
45,777
-1,934
-4% -$120K 0.09% 159
2022
Q1 		$2.84M Sell
47,711
-9,629
-17% -$616K 0.07% 168
2021
Q4 		$4.16M Buy
57,340
+1,499
+3% +$103K 0.1% 120
2021
Q3 		$3.9M Buy
55,841
+15,108
+37% +$1.06M 0.1% 116
2021
Q2 		$2.81M Buy
40,733
+17,718
+77% +$1.18M 0.08% 139
2021
Q1 		$1.49M Buy
23,015
+5,693
+33% +$367K 0.06% 169
2020
Q4 		$1.01M Sell
17,322
-4,588
-21% -$277K 0.04% 164
2020
Q3 		$1.38M Buy
21,910
+4,905
+29% +$340K 0.07% 142
2020
Q2 		$1.31M Buy
17,005
+2,985
+21% +$229K 0.09% 132
2020
Q1 		$1.05M Buy
14,020
+5,423
+63% +$375K 0.08% 138
2019
Q4 		$558K Buy
+8,597
New +$560K 0.05% 207

Other funds holding GILD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

IEQ Capital's GILD Position: Q2 2026 in Review

IEQ Capital increased its Gilead Sciences (GILD) stake by 90% in Q2 2026, buying an estimated $2.11M and bringing the position to 33,739 shares worth $4.26M. The position accounts for 0.02% of the portfolio, ranked #550.

IEQ Capital first reported a position in GILD in Q4 2019 and has held it in 27 quarters since. The position peaked at $15M in Q4 2025. 2,268 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • IEQ Capital held 33,739 shares of Gilead Sciences worth $4.26M as of Q2 2026.
  • IEQ Capital bought 15,992 Gilead Sciences shares in Q2 2026, an estimated $2.11M.
  • Gilead Sciences made up 0.02% of IEQ Capital's portfolio in Q2 2026, its #550 holding.
  • IEQ Capital first reported a position in Gilead Sciences in Q4 2019 and has held it in 27 quarters since.
  • IEQ Capital's Gilead Sciences position peaked at $15M in Q4 2025.
  • 2,268 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on IEQ Capital's 13F filing for Q2 2026, filed 11 Aug 2026.